Research Article
Volume 6 Issue 1 - 2022
Antidiabetic and Antioxidant Activities of Ethanolic Extract of Anogeissus leiocarpus in Alloxan-Induced Type 1 Diabetes Mellitus in Wistar Rats
Sabina Mbafan Num-Adom1,2, Sani Adamu1, Tagang Aluwong3, Ngozi Ejum Ogbuagu3, Ismaila Alhaji Umar4 and King Akpofure Nelson Esievo1*
1Department of Veterinary Pathology, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria
2Department of Veterinary Pathology, College of Veterinary Medicine, University of Agriculture, Makurdi, Benue State, Nigeria
3Department of Veterinary Physiology, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria
4Department of Biochemistry, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Nigeria
*Corresponding Author: King Akpofure Nelson Esievo, Department of Veterinary Pathology, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria, Nigeria.
Received: June 16, 2022; Published: June 30, 2022


Antidiabetic property of Anogeissus leiocarpus on hyperglycaemia-induced oxidative stress in spleen, kidney, heart, brain and liver. The study investigated antidiabetic and antioxidant effects of A. leiocarpus ethanolic extract in alloxan-induced diabetes mellitus and hyperglycaemia-induced oxidative stress in Wistar rats. Four groups of nine rats each; non-diabetic (ND), diabetic untreated (DU), diabetic insulin-treated (DI) and diabetic extract-treated (DE) were assayed for fasting blood glucose and oxidative stress biomarkers. Blood glucose significantly (P < 0.001) increased, as well as oxidative stress biomarkers, malondialdehyde (MDA) (P < 0.05; 0.002; 0.001) and significant (P < 0.05) variations in superoxide dismutase (SOD), catalase and glutathione (GSH) in DU. Ethanolic extract of A. leiocarpus significantly (P < 0.001) reversed the blood glucose and the oxidative stress biomarker to normal in DE as in DI. A. leiocarpus can serve as non-conventional treatment for diabetes-induced oxidative stress.

Keywords: Antidiabetic; Antioxidant; Oxidative Stress; Anogeissus leiocarpus; Wistar Rats


  1. Punthakee Z., et al. “Definition, classification and diagnosis of diabetes, pre-diabetes and metabolic syndrome diabetes”. Canadian Journal of Diabetes 42 (2018): 10-15.
  2. Fowler MJ. “Microvascular and macrovascular complications of diabetes”. Clinical Diabetes2 (2008): 77-82.
  3. World Health Organization. “Global report on diabetes. 1. Diabetes Mellitus - epidemiology. 2. Diabetes Mellitus - prevention and control. 3. Diabetes, Gestational. 4. Chronic Disease. 5. Public Health. I”. World Health Organization. France (2016).
  4. Guariguata L., et al. “Global estimates of diabetes prevalence for 2013 and projections for 2035”. Diabetes Research and Clinical Practice 103 (2014): 137-149.
  5. Amjad S., et al. “A novel strategy of nanotized herbal drugs and their delivery in the treatment of diabetes: Present status and future prospects”. Journal of Herbal Medicine 17 (2019): 100279.
  6. Armstrong DG., et al. “Diabetic foot ulcers and their recurrence”. New England Journal of Medicine24 (2017): 2367-2375.
  7. Skrepnek GH., et al. “Health care service and outcomes among an estimated 6.7 million ambulatory care diabetic foot cases in the US”. Diabetes Care7 (2017): 936-942.
  8. Zhu, L., et al. “Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes”. Cell Metabolism 31 (2020): 1068-1077.
  9. Kawahito S., et al. “Problems associated with glucose toxicity: Role of hyperglycaemia-induced oxidative stress”. World Journal of Gastroenterology33 (2009): 4137-4142.
  10. Giacco F and Brownlee M. “Oxidative stress and diabetic complications”. Circulatory Research 107 (2010): 1058-1070.
  11. Lenzen S. “Alloxan and streptozotocin diabetes”. Advance Research Institutes of Diabetes Animals4 (2010): 113-122.
  12. Zhang X., et al. “A1C level and future risk of diabetes: A systematic review”. Diabetes Care 33 (2010): 1665-1673.
  13. Kang P., et al. “Antiinflammatory effects of anethole in lipopolysaccharide-induced acute lung injury in mice”. Life Science 93 (2013): 955-961.
  14. Babu PA., et al. “A database of 389 medicinal plants for diabetes”. Bioinformation4 (2006): 130-131.
  15. N'guessan K., et al. “Ethnobotanical study of plants used to treat diabetes, in traditional medicine, by Abbey and Krobou People of Agboville (Côte-d’Ivoire)”. American Journal of Scientific Research 4 (2009): 45-58.
  16. Rugerio-Escalona C., et al. “Diabetes and Metabolism Disorders Medicinal Plants: A Glance at the Past and a Look to the Future 2018: Anti-hyperglycemic Activity of Hamelia patens Jacq. Extracts”. Evidence-based Complementary and Alternative Medicine (2018).
  17. Zaid H., et al. “Diabetes and metabolism disorders medicinal plants: A glance at the past and a look to the future 2018”. Evidence-based Complementary and Alternative Medicine (2018): 5843298.
  18. Num SM., et al. “Some observations in Wistar rats administered ethanol extracts of the stem barks of Anogeissus leiocarpus”. Asian Journal of Pharmacology and Toxicology3 (2014): 4-10.
  19. Dey L., et al. “Alternative therapies for type 2 diabetes”. Alternative Medicine Review 7 (2002): 45-58.
  20. Kooti W., et al. “The role of medicinal plants in the treatment of diabetes: A systematic review”. Electronic Physician1 (2016): 1832-1842.
  21. Raj R and Tripathi SS. “Medications of diabetes mellitus and antidiabetic medicinal plants: A review”. International Journal of Indian Herbs and Drugs 1 (2016): 19-28.
  22. Esievo KAN., et al. “Elevated serum sialic acids, a potent biomarker of alloxan-induced type 1 diabetes in dogs by ethanolic extract of Anogeissus leiocarpus”. Journal of Diabetes and Metabolic Disorders (2021): 1-8.
  23. Aluwong T., et al. “Amelioration of hyperglycaemia, oxidative stress and dyslipidaemia in alloxan-induced diabetic Wistar rats treated with probiotic and vitamin C”. Nutrients151 (2016): 1-15.
  24. Elsner M., et al. “Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin”. Diabetolgia 12 (2007): 1528-1533.
  25. Gaikwad SB., et al. “Phytochemicals for diabetes management”. Pharmaceutical Crops1 (2014): 11-28.
  26. Mukherjee PK., et al. “Leads from Indian medicinal plants with hypoglycemic potentials”. Journal of Ethnopharmacology 106 (2006): 1-28.
  27. Bnouham M., et al. “Medicinal plants with potential antidiabetic activity - A review of ten years of herbal medicine research (1990-2000)”. International Journal of Diabetes and Metabolism 14 (2006): 1-25.
  28. Govindappa M. “A review on role of plant(s) extracts and it’s phytochemicals for the management of diabetes”. Journal of Diabetes and Metabolism 6 (2015): 565.
  29. Bacanli M., et al. “Effects of phytochemicals against diabetes”. Advances in Food and Nutrition Research (2019): 1-28.
  30. Kanadhasan R and Venkataraman S. “In vitro capacity and in vivo antioxidant potency of sedimental extract of Tinospora cordifolia in streptozotocin induced type 2 diabetes”. Avicenna Journal of Phytomedicine1 (2013): 7-24.
  31. Kumawat M., et al. “Antioxidant enzymes and lipid peroxidation in Type 2 diabetes mellitus patients with and without nephropathy”. North American Journal of Medical Sciences3 (2013): 213-219.
  32. Tiwari B., et al. “Markers of Oxidative stress during diabetes mellitus”. Journal of Biomarkers (2013): 378790.
  33. De Souza Bastos A., et al. “Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients”. Journal of Diabetes and its Complications8 (2016): 1593-1599.
  34. Kayama Y., et al. “Diabetic Cardiovascular Disease Induced by Oxidative Stress”. International Journal of Molecular Science 10 (2015): 25234-25263.
  35. Kesavulu MM., et al. “Lipid peroxides and antioxidant enzyme levels in type 2 diabetics with microvascular complications”. Diabetes and Metabolism3 (2000): 387- 392.
  36. Asmat U., et al. “Diabetes mellitus and oxidative stress: A concise Review”. Saudi Pharmaceutical Journal 24 (2016): 547-553.
  37. Volpe CMO., et al. “Cellular death, reactive oxygen species (ROS) and diabetic complications”. Cell Death and Disease119 (2018): 1-9.
  38. Sireesha K and Rao SP. “Oxidative stress and diabetes: An overview”. Asian Journal of Pharmacology Clinical Research1 (2015): 15-19.
  39. Ahmed D., et al. “Antidiabetic, antioxidant, antihyperlipidemic effect of extract of Euryale ferox salisb. with enhanced histopathology of pancreas, liver and kidney in streptozotocin induced diabetic rats”. Springer Plus 4 (2015): 315.
  40. Chikezie PC., et al. “Oxidative stress in diabetes mellitus”. Integrative Obesity and Diabetes3 (2015): 71-79.
  41. Ebokaiwe AP., et al. “Alteration in sperm characteristics, endocrine balance and redox status in rats rendered diabetic by streptozotocin treatment: attenuating role of Loranthus micranthus”. Redox Report1 (2018): 195-205.
  42. Muriach M., et al. “Diabetes and the brain: oxidative stress, inflammation, and autophagy”. Oxidative Medicine and Cellular Longevity (2014).
  43. Sebeková K., et al. “Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis: Amelioration by liver transplantation”. Journal of Hepatolology 36 (2002): 66-71.
  44. Mahmoud AM., et al. “Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats”. Journal of Diabetes Complications 26 (2012): 483-490.
  45. Aluwong T., et al. “Effect of yeast probiotic on growth, antioxidant enzyme activities and malondialdehyde concentration of broiler chickens”. Antioxidants 2 (2013): 326-339.
  46. Yilmaz HR., et al. “Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver”. Journal of Biochemistry and Molecular Toxicology 18 (2004): 234-238.
  47. Okutan H., et al. “Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart”. Clinical Biochemistry 38 (2005): 191-196.
  48. Genet S., et al. “Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: Effect of vanadate and fenugreek (Trigonella foenum graecum)”. Molecular Cell Biochemistry 236 (2002): 7-12.
  49. Koya D., et al. “Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats”. Journal of American Society of Nephrology3 (2003): S250-S253.
  50. Guido MC., et al. “The effects of diabetes induction on the rat heart: differences in oxidative stress, inflammatory cells, and fibrosis between subendocardial and interstitial myocardial areas”. Hindawi Oxidative Medicine and Cellular Longevity (2017): 5343972.
  51. Parveen K., et al. “Protective effects of Pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats”. Chemical and Biological Interactions 186 (2010): 219-227.
  52. Lucchesi AN., et al. “Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease”. Acta Cirurgica Brasileira7 (2013): 502-508.
  53. Mohammed J., et al. “Mechanisms of diabetes-induced liver damage: The role of oxidative stress and inflammation”. Sultan Qaboos University Medical Journal2 (2016): 32-41.
  54. Lipinski B. “Pathophysiology of oxidative stress in diabetes mellitus”. Journal of Diabetes and its Complications4 (2001): 203-210.
  55. Kirkman HN and Gaetani GF. “Mammalian catalase: a venerable enzyme with new mysteries”. Trends in Biochemical Sciences1 (2007): 44-50.
  56. Boots AW., et al. “Health effects of quercetin: from antioxidant to nutraceutical”. European Journal of Pharmacology 585.2-3 (2008): 325-337.
  57. Otitoju O., et al. “Oxidative stress and superoxide dismutase activity in brain of rats fed with diet containing permethrin”. Biokemistri2 (2008): 93-98.
  58. Abdel-Daim MM., et al. “Alleviation of drugs and chemicals toxicity: biomedical value of antioxidants”. Oxidative Medicine and Cellular Longevity (2018).
  59. Maritim AC., et al. “Diabetes, oxidative stress, and antioxidants: a review”. Journal of Biochemistry and Molecular Toxicology1 (2003): 24-38.
  60. Singhal SS., et al. “Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling”. Toxicology and Applied Pharmacology3 (2015): 361-370.
  61. Guven A., et al. “Effects of melatonin on streptozotocin-induced diabetic liver injury in rats”. Acta Histochemical 108 (2006): 85-93.
  62. Romagnoli M., et al. “Xanthine oxidase-induced oxidative stress causes activation of NF-kappaB and inflammation in the liver of type I diabetic rats”. Free Radical Biology and Medicine 49 (2010): 171-177.
  63. Yagmur E., et al. “Elevation of Nepsilon-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis”. Clinical Biochemistry 39 (2006): 39-45.
  64. Aydın S., et al. “Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control”. Clinical Biochemistry 34 (2001): 65-70.
  65. Chigayo K., et al. “Phytochemical and antioxidant properties of different solvent extracts of Kirkia wilmsii tubers”. Asian Pacific Journal of Tropical Biomedicine12 (2016): 1037-1043.
Citation: King Akpofure Nelson Esievo., et al. “Antidiabetic and Antioxidant Activities of Ethanolic Extract of Anogeissus leiocarpus in Alloxan-Induced Type 1 Diabetes Mellitus in Wistar Rats”. EC Diabetes and Metabolic Research 6.1 (2022): 38-49.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

December Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 21, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.